Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ISPC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Defective Corporate Act - Prior Reverse Split Improperly Executed (new) — The September 2024 reverse split was legally defective due to missing Delaware filing, raising questions about corporate governance oversight and internal controls.
- Second Reverse Split In Under Two Years (new) — Multiple reverse splits in short succession typically signal persistent stock price weakness and potential ongoing compliance challenges with exchange listing requirements.
iSpecimen completes 1-for-40 reverse stock split to regain Nasdaq compliance
Filed May 1, 2026 · Period ending April 29, 2026 · ~1 min read
Key Changes
-
high
Executed 1-for-40 reverse stock split effective April 27, reducing outstanding shares from 52.6M to 1.3M to meet Nasdaq's minimum bid price requirement and avoid delisting.
Item 5.03 verify on EDGAR → -
high
Company disclosed that a prior 1-for-20 reverse split from September 2024 was defective because required Delaware filing was never submitted; Board ratified this error on April 29, 2026.
Item 5.03 verify on EDGAR → -
medium
All stock options, warrants, and restricted stock units were proportionately adjusted for the split; fractional shares were rounded up to benefit shareholders.
Item 5.03 verify on EDGAR → -
medium
Filed Fifth Amended and Restated Certificate of Incorporation with Delaware to effectuate the reverse split and correct prior corporate governance defects.
Item 5.03 verify on EDGAR →
Summary
iSpecimen executed a dramatic 1-for-40 reverse stock split to boost its share price and regain compliance with Nasdaq's minimum bid price requirement. The split reduced outstanding shares from 52.6 million to approximately 1.3 million, with trading beginning on a split-adjusted basis April 28, 2026.
Management stated the move was also intended to attract institutional investors who often have minimum price thresholds. The filing revealed a significant governance issue: a prior 1-for-20 reverse split from September 2024 was legally defective because the company never filed the required certificate with Delaware. The Board ratified this error under Delaware law and filed corrective documents.
This marks the company's second reverse split in under two years, a pattern that typically indicates persistent stock price weakness. Retail investors should monitor whether the split successfully maintains Nasdaq compliance over the coming months. Watch for the company's next quarterly report to assess whether the higher share price attracts meaningful institutional investment or if further dilution or compliance issues emerge.
Section-by-Section Diff
Event · Item 5.03 — Amendments to Articles of Incorporation or Bylaws
iSpecimen completed a 1-for-40 reverse stock split to regain Nasdaq compliance and attract institutional investors.
Added in current filing · verify on EDGAR →
The Reverse Stock Split was intended to increase the per share trading price of the Company’s common stock to better position the Company to attract certain institutional and other investors and to regain compliance with the minimum bid price requirement for continued listing of the Company’s common stock on Nasdaq.
The reverse split was designed to boost the stock price to meet Nasdaq's minimum bid price requirement and avoid delisting. It also aims to attract institutional investors who may have minimum price thresholds for investment.
Added in current filing · verify on EDGAR →
In addition, proportionate adjustments were made to (i) the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock, (ii) the number of shares of common stock issuable upon the vesting of outstanding restricted stock units, and (iii) the number of shares reserved for issuance pursuant to the Company’s equity incentive plans.
All outstanding stock options, warrants, restricted stock units, and equity plan share reserves were proportionately adjusted for the 1-for-40 reverse split. This maintains the economic value of these instruments while reflecting the reduced share count.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
No fractional shares were issued in connection with the Reverse Stock Split. Any fractional share of common stock that would otherwise have resulted from the Reverse Stock Split was rounded up to the nearest whole share.
Shareholders received no fractional shares from the reverse split. Any fractional shares were rounded up to the nearest whole share, meaning shareholders benefited from rounding rather than receiving cash for fractional interests.
Event · Item 8.01 — Other Events
iSpecimen announced a reverse stock split via press release on April 24, 2026.
Added in current filing · verify on EDGAR →
On April 24, 2026, the Company issued a press release announcing the Reverse Stock Split.
The company publicly announced a reverse stock split through a press release. Reverse stock splits reduce the number of outstanding shares while proportionally increasing the share price, often used to meet exchange listing requirements or improve stock price perception. The specific ratio and effective date are detailed in the referenced press release exhibit.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Fifth Amended and Restated Certificate of Incorporation, effective April 29, 2026
The company filed its Fifth Amended and Restated Certificate of Incorporation, which became effective April 29, 2026. This represents a material change to the company's governing documents, though the specific amendments are not detailed in this 8-K filing itself. A Certificate of Validation was also filed the same day, which typically confirms the validity of corporate actions.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Press Release dated April 24, 2026
The company issued a press release on April 24, 2026, which is attached as an exhibit. The content of the press release is not provided in this 8-K body, but it likely relates to the certificate of incorporation amendments or other corporate developments.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify